Journal
ISCIENCE
Volume 25, Issue 7, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.isci.2022.104669
Keywords
-
Categories
Funding
- NIH [AR076821, K08HL130601, 5R21AG060211, CA04659229]
Ask authors/readers for more resources
Intestinal dysbiosis is associated with systemic sclerosis (SSc), and this study reveals the mechanism by which trimethylamine N-oxide (TMAO) converts skin fibroblasts and other cells into myofibroblasts via the R-like et-Jet:PERK signaling pathway.
Intestinal dysbiosis is prominent in systemic sclerosis (SSc), but it remains unknown how it contributes to microvascular injury and fibrosis that are hallmarks of this disease. Trimethylamine (TMA) is generated by the gut microbiome and in the host converted flavin-containing monooxygenase (FMO3) into trimethylamine N-oxide (TMAO), which has been implicated in chronic cardiovascular and metabolic diseases. Using cell culture systems and patient biopsies, we now show that TMAO reprograms skin fibroblasts, vascular endothelial cells, and adipocytic progenitor cells into myofibroblasts via the putative TMAO receptor protein R-like et-Jet:plasmic reticulum kinase (PERK). Remarkably, FMO3 was detected in skin fibroblasts and its expression stim-:ated by TGF-beta 1. Moreover, FMO3 was elevated in SSc skin biopsies and in SSc fibroblasts. A meta-organismal pathway thus might in SSc link gut microbiome to vascular remodeling and fibrosis via stromal cell reprogramming, implicating the FMO3-TMAO-PERK axis in pathogenesis, and as a promising target for therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available